of innovative I&I biological products. We look forward to his contributions and insights as we strive to bring transformative therapies to patients in need." About Scinai Immunotherapeutics: Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) is a...
Jennifer Tamberino – who had been Regional Business Director, East, National Sales –was promoted to backfill Foy's former position as national sales director. "It is with incredible excitement that we announce Don's promotion to lead our sales,...
Ventures Company opens up completely new opportunities for us to tap into further markets, expand our technology platform and develop new products,” said Ulrike Sailer, CEO of Neoplas Med. “We are not only taking a big step forward, but also...
in Houston, USA, from November 6 to 10. BH3120 is a novel anticancer drug based on Hanmi's proprietary dual antibody platform, "Pentambody." This technology enables a single antibody to simultaneously bind to two distinct targets, allowing for a...
You live every day not knowing what's going to happen." Terumo BCT makes the Spectra Optia™ Apheresis System, a platform used to collect and remove sickled cells from the blood of patients with SCD. The company advocates globally for patients with...
electrophysiological dysfunction of TDP-43 M337V mutated motor neurons, showcasing the potential for NUZ-001 to be a transformative treatment for ALS. Importantly, these findings reinforce the promising efficacy results seen in Neurizon's Phase 1...
Axonal.AI today unveiled its groundbreaking platform, designed to significantly accelerate speed to market in the life sciences industry. At a time when rapid commercialization is more critical than ever, Axonal.AI's cutting-edge technology...
(SCD) with recurrent vaso-occlusive crises or (2) transfusion-dependent β-thalassemia (TDT). Read the Full Prescribing Information here. "With our Cell and Gene Therapy Center of Excellence established over seven years ago, Orsini is...
frequent speaker and guest lecturer around the world. The privately-held company is based in Chicago, Illinois. For more information please visit www.ResQPharma.com.
organization with an efficient process-oriented approach and track record in the diagnostic imaging industry. For more information please visit, www.bracco.com
Chief Executive Officer of SystImmune, commented, "Our mission at SystImmune is to bring therapies that can provide transformative clinical benefit to patients. As BL-M17D1 is developed using our next generation linker and payload technology, the...
Transposon Therapeutics, a biotechnology company developing a platform of novel, orally administered therapies for the treatment of neurodegenerative and aging-related diseases, including Alzheimer's disease, announced that results from its Phase...
with locally advanced unresectable or metastatic malignant perivascular epithelioid cell tumor (PEComa). For more information please visit, www.aadibio.com
proprietary multi-omics database of exceptional cancer survivors. 10x Genomics' Visium HD assay, enables researchers to perform whole transcriptome spatial gene expression analysis at single cell-scale resolution. The assay will enable Cure51's...
GoodRx the leading prescription savings platform in the U.S., announced the rollout of its new e-commerce solution, with Opill® as its launch partner. This new seamless direct-to-consumer shopping experience allows consumers to order eligible...
to offer patients a less invasive, more comfortable treatment option compared to traditional injections, potentially transforming the standard of care for OAB. Vensica's needle-free drug delivery system aims to be a urology treatment platform for...
elderly, is divided into two types: dry and wet. Often occurring in the late stages of AMD progression, GA is an advanced form of dry AMD that causes damage to retinal tissue, eventually leading to blindness. In the US alone, approximately 1.5...
once-daily plasma kallikrein inhibitor, and is advancing a pipeline of small-molecule and protein therapies. For more information, please visit www.biocryst.com
future, Great Bay Bio will adhere to technological innovation and work with global partners to further promote the transformation and development of the biopharmaceutical industry, so that patients around the world can enjoy the benefits brought by...
outcomes, and quality of life measures. The plan is to enroll fifty-six participants to allow an assessment of ATX-01's performance in this population. Dr. Judy Walker, Chief Medical Officer of ARTHEx, added, "The ArthemiR™ trial is designed to...
